13F HOLDINGS REPORT
Affinity Asset Advisors, LLC
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0001839882-24-038904
Total Value
$732.8M
Positions
86
Other Managers
0
Confidential Omitted
No
Holdings (86)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | XENON PHARMACEUTICALS INC | XENE | 1,144,021 | $45.0M | 6.15% |
| 2 | CASSAVA SCIENCES INC | 14817C107 | 1,449,300 | $42.7M | 5.82% |
| 3 | APOGEE THERAPEUTICS INC | APGE | 664,198 | $39.0M | 5.32% |
| 4 | NUVALENT INC | NUVL | 337,500 | $34.5M | 4.71% |
| 5 | ARCELLX INC | ACLX | 400,000 | $33.4M | 4.56% |
| 6 | ALKERMES PLC | ALKS | 1,000,000 | $28.0M | 3.82% |
| 7 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,400,000 | $25.2M | 3.44% |
| 8 | MADRIGAL PHARMACEUTICALS INC | MDGL | 100,000 | $21.2M | 2.90% |
| 9 | CRINETICS PHARMACEUTICALS IN | CRNX | 400,000 | $20.4M | 2.79% |
| 10 | NURIX THERAPEUTICS INC | NRIX | 860,399 | $19.3M | 2.64% |
| 11 | VERA THERAPEUTICS INC | VERA | 435,000 | $19.2M | 2.62% |
| 12 | VERONA PHARMA PLC | 925050106 | 650,000 | $18.7M | 2.55% |
| 13 | TEVA PHARMACEUTICAL INDS LTD | 881624209 | 1,000,000 | $18.0M | 2.46% |
| 14 | AUTOLUS THERAPEUTICS PLC | AUTL | 4,500,000 | $16.3M | 2.23% |
| 15 | CENTESSA PHARMACEUTICALS PLC | CNTA | 965,612 | $15.4M | 2.11% |
| 16 | INOZYME PHARMA INC | 45790W108 | 2,822,318 | $14.8M | 2.01% |
| 17 | SPYRE THERAPEUTICS INC | SYRE | 498,420 | $14.7M | 2.00% |
| 18 | OMEROS CORP | OMER | 21,525,000 | $14.6M | 2.00% |
| 19 | KURA ONCOLOGY INC | KURA | 687,785 | $13.4M | 1.83% |
| 20 | COHERUS BIOSCIENCES INC | 19249HAB9 | 16,625,000 | $13.1M | 1.78% |
| 21 | ESTABLISHMENT LABS HLDGS INC | ESTA | 290,447 | $12.6M | 1.72% |
| 22 | VIRIDIAN THERAPEUTICS INC | VRDN | 525,000 | $11.9M | 1.63% |
| 23 | WAVE LIFE SCIENCES LTD | WVE | 1,400,000 | $11.5M | 1.57% |
| 24 | KARYOPHARM THERAPEUTICS INC | KPTI | 12,250,000 | $9.6M | 1.31% |
| 25 | ORUKA THERAPEUTICS INC | ORKA | 349,836 | $8.6M | 1.17% |
| 26 | REZOLUTE INC | RZLT | 1,700,000 | $8.2M | 1.13% |
| 27 | MERUS N V | N5749R100 | 161,741 | $8.1M | 1.10% |
| 28 | ASTRIA THERAPEUTICS INC | 04635X102 | 725,106 | $8.0M | 1.09% |
| 29 | BEIGENE LTD | BEIGF | 35,000 | $7.9M | 1.07% |
| 30 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 472,390 | $7.8M | 1.07% |
| 31 | BRIDGEBIO PHARMA INC | BBIO | 300,000 | $7.6M | 1.04% |
| 32 | ELIEM THERAPEUTICS INC | CLYM | 1,500,000 | $7.6M | 1.04% |
| 33 | AXSOME THERAPEUTICS INC | AXSM | 80,000 | $7.2M | 0.98% |
| 34 | ERASCA INC | ERAS | 2,499,431 | $6.8M | 0.93% |
| 35 | GERON CORP | GERN | 1,500,000 | $6.8M | 0.93% |
| 36 | ANAPTYSBIO INC | ANABV | 200,000 | $6.7M | 0.91% |
| 37 | PERSPECTIVE THERAPEUTICS INC | CATX | 500,000 | $6.7M | 0.91% |
| 38 | IMMUNOVANT INC | IMVT | 225,000 | $6.4M | 0.88% |
| 39 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 325,000 | $6.3M | 0.86% |
| 40 | ARS PHARMACEUTICALS INC | SPRY | 400,000 | $5.8M | 0.79% |
| 41 | VAXCYTE INC | PCVX | 50,000 | $5.7M | 0.78% |
| 42 | ARVINAS INC | ARVN | 225,000 | $5.5M | 0.76% |
| 43 | TERNS PHARMACEUTICALS INC | TERN | 600,000 | $5.0M | 0.68% |
| 44 | SPRINGWORKS THERAPEUTICS INC | 85205L107 | 147,500 | $4.7M | 0.64% |
| 45 | CULLINAN THERAPEUTICS INC | CGEM | 263,817 | $4.4M | 0.60% |
| 46 | TRAVERE THERAPEUTICS INC | TVTX | 5,000,000 | $4.3M | 0.59% |
| 47 | CELLDEX THERAPEUTICS INC NEW | CLDX | 125,000 | $4.2M | 0.58% |
| 48 | MINERALYS THERAPEUTICS INC | MLYS | 350,000 | $4.2M | 0.58% |
| 49 | NOVAVAX INC | NVAX | 300,000 | $3.8M | 0.52% |
| 50 | INSMED INC | INSM | 50,000 | $3.6M | 0.50% |
| 51 | PERCEPTIVE CAP SOLUTIONS COR | G70077105 | 350,000 | $3.5M | 0.48% |
| 52 | GALECTIN THERAPEUTICS INC | GALT | 1,211,400 | $3.3M | 0.45% |
| 53 | NEXTCURE INC | NXTC | 2,302,598 | $3.2M | 0.43% |
| 54 | SUMMIT THERAPEUTICS INC | SMMT | 140,000 | $3.1M | 0.42% |
| 55 | SAVARA INC | SVRA | 700,000 | $3.0M | 0.41% |
| 56 | NKARTA INC | NKTX | 650,000 | $2.9M | 0.40% |
| 57 | MIRUM PHARMACEUTICALS INC | MIRM | 75,000 | $2.9M | 0.40% |
| 58 | IMMATICS N.V | IMTX | 250,000 | $2.9M | 0.39% |
| 59 | SYROS PHARMACEUTICALS INC | 87184Q206 | 1,234,200 | $2.7M | 0.36% |
| 60 | HELIX ACQUISITION CORP II | HLXC | 250,000 | $2.6M | 0.36% |
| 61 | CONTEXT THERAPEUTICS INC | CNTX | 1,321,153 | $2.6M | 0.35% |
| 62 | INARI MED INC | 45332Y109 | 60,000 | $2.5M | 0.34% |
| 63 | ROIVANT SCIENCES LTD | ROIV | 201,587 | $2.3M | 0.32% |
| 64 | IMMUNOVANT INC | IMVT | 78,000 | $2.2M | 0.30% |
| 65 | KEZAR LIFE SCIENCES INC | KZR | 2,511,778 | $1.9M | 0.27% |
| 66 | COMPASS PATHWAYS PLC | CMPS | 300,512 | $1.9M | 0.26% |
| 67 | TECTONIC THERAPEUTIC INC | TECX | 58,331 | $1.8M | 0.24% |
| 68 | NEWAMSTERDAM PHARMA COMPANY | NAMSW | 212,974 | $1.5M | 0.20% |
| 69 | SOLENO THERAPEUTICS INC | SLNO | 25,000 | $1.3M | 0.17% |
| 70 | AEROVATE THERAPEUTICS INC | 008064107 | 600,000 | $1.3M | 0.17% |
| 71 | Q32 BIO INC | QTTB | 27,777 | $1.2M | 0.17% |
| 72 | VERASTEM INC | VSTM | 400,000 | $1.2M | 0.16% |
| 73 | BIOMARIN PHARMACEUTICAL INC | BMRN | 15,000 | $1.1M | 0.14% |
| 74 | ZURA BIO LTD | ZURA | 223,335 | $906,740 | 0.12% |
| 75 | PUMA BIOTECHNOLOGY INC | PBYI | 250,000 | $637,500 | 0.09% |
| 76 | REPARE THERAPEUTICS INC | 760273102 | 173,351 | $596,327 | 0.08% |
| 77 | KYVERNA THERAPEUTICS INC | KYTX | 119,900 | $586,311 | 0.08% |
| 78 | ADAGIO MED HLDGS INC | 00534B100 | 213,235 | $550,146 | 0.08% |
| 79 | IMMATICS N.V | IMTX | 187,204 | $430,569 | 0.06% |
| 80 | AVALO THERAPEUTICS INC | AVTX | 45,000 | $425,700 | 0.06% |
| 81 | VOYAGER THERAPEUTICS INC | VYGR | 51,727 | $302,603 | 0.04% |
| 82 | NEUROBO PHARMACEUTICALS IN | MTVA | 89,222 | $282,834 | 0.04% |
| 83 | GENELUX CORPORATION | GNLX | 100,000 | $237,000 | 0.03% |
| 84 | AADI BIOSCIENCE INC | WHWK | 47,019 | $96,859 | 0.01% |
| 85 | PROMIS NEUROSCIENCES INC | PMN | 30,643 | $38,304 | 0.01% |
| 86 | ROCKET PHARMACEUTICALS INC | RCKTW | 75,000 | $5,250 | 0.00% |